E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/30/2019 in the Prospect News Structured Products Daily.

New Issue: UBS sells $255,000 buffer autocallable contingent yield notes on two ETFs

By Sarah Lizee

Olympia, Wash., Aug. 30 – UBS AG London Branch priced $255,000 of buffer autocallable contingent yield notes with memory interest due Aug. 31, 2022 linked to the lesser performing of the SPDR S&P Biotech ETF and the VanEck Vectors Oil Services ETF, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent monthly coupon at an annual rate of 9% if each asset closes at or above its 80% coupon barrier on the review date for that quarter, plus any previously unpaid coupons.

The notes will be called at par if each asset closes at or above 95% of its initial level on any monthly review date after six months.

The payout at maturity will be par unless either asset finishes below its 80% buffer level, in which case investors will be exposed to any losses of the worse performing asset beyond 20%.

UBS Securities LLC and UBS Investment Bank are the agents.

Issuer:UBS AG, London Branch
Issue:Buffer autocallable contingent yield notes
Underlying assets:SPDR S&P Biotech ETF and VanEck Vectors Gold Miners ETF
Amount:$255,000
Maturity:Aug. 31, 2022
Coupon:9%, payable monthly if each asset closes at or above coupon barrier on observation date
Price:Par
Call:Notes will be called at par if each asset closes at or above its initial level on any monthly review date after six months
Payout at maturity:Par unless each asset closes below buffer level, in which case 1% loss for each 1% decline of lesser performing asset beyond buffer
Initial levels:$80.20 for biotech, $11.01 for oil
Call thresholds:$76.19 for biotech, $10.46 for oil; 95% of initial levels
Coupon barriers:$64.16 for biotech, $8.81 for oil; 80% of initial levels
Buffer levels:$64.16 for biotech, $8.81 for oil; 80% of initial levels
Pricing date:Aug. 26
Settlement date:Aug. 29
Agents:UBS Financial Services Inc. and UBS Investment Bank
Fees:2.75%
Cusip:90270KJ34

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.